Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Income from Continuing Operations: 2011-2012

Historic Income from Continuing Operations for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Mar 2012 value amounting to -$7.4 million.

  • Sonoma Pharmaceuticals' Income from Continuing Operations rose 63.49% to -$954,000 in Q4 2012 from the same period last year, while for Dec 2012 it was -$4.6 million, marking a year-over-year increase of 36.33%. This contributed to the annual value of -$7.4 million for FY2012, which is 6.50% up from last year.
  • Per Sonoma Pharmaceuticals' latest filing, its Income from Continuing Operations stood at -$7.4 million for FY2012, which was up 6.50% from -$7.9 million recorded in FY2011.
  • In the past 5 years, Sonoma Pharmaceuticals' Income from Continuing Operations ranged from a high of -$7.4 million in FY2012 and a low of -$7.9 million during FY2011.
  • Over the past 2 years, Sonoma Pharmaceuticals' median Income from Continuing Operations value was -$7.7 million (recorded in 2011), while the average stood at -$7.7 million.
  • Data for Sonoma Pharmaceuticals' Income from Continuing Operations shows a peak YoY climbed of 6.50% (in 2012) over the last 5 years.
  • Yearly analysis of 2 years shows Sonoma Pharmaceuticals' Income from Continuing Operations stood at -$7.9 million in 2011, then grew by 6.50% to -$7.4 million in 2012.